Author: Mamatha NS, Rohit S, R Narahari* and Brijesh Byrappa

The Ameloblastic fibrodentinoma (AFD) is a minor variation of an Ameloblastic fibroodontoma with a predominant dentin formation. It is a rare mixed odontogenic tumour composed of neoplastic odontogenic epithelium and mesenchyme with dentin. This paper presents a rare case of Ameloblastic fibrodentinoma in the anterior mandible, which was excised and post-operative recovery was uneventful.

Click on the link below to access the article:
https://actascientific.com/ASDS/ASDS-02-0278.php

Author: Dr. Brijesh Byrappa, Dr. Zainab Abubaker, Dr. Swathi Mani, Dr. Narahari Ranganatha and Dr. Mohammed Yunus

Patients are highly inclined towards aesthetic outlook in the recent years. More number of patients visit dental offices with the complaint of greyish-black gums. The core reason for this pigmentation of the gingiva is due to the melanoblastic activity. There are wide range of treatment options for depigmentation of the gingiva. They include scalpel gingivectomy, free gingival graft, bur abrasion, use of chemicals, electrosurgery, cryosurgery and lasers. Among the various techniques, lasers provide promising therapeutic option as they are simple, painless, effective and a reliable tool. Here, we report gingival depigmentation of a patient using diode laser technique.

Click on the link below to access the article:
http://www.ijramr.com/issue/clinical-application-diode-laser-gingival-hyperpigmentation-enhance-aesthetics

Periodontitis is an inflammatory disease that causes destruction of tooth supporting tissues, characterized by multifactorial etiology with pathogenic bacteria being the primary etiologic agents that dwells the subgingival area. Local drug delivery system consists of antimicrobial dosages that produces more constant and prolonged concentration profiles within the subgingival tissue and provides better access into the periodontal pockets. It addresses the critical distress of exposing the patient to adverse effects of systemic administration. This article reviews the literature and presents novel trends such as osteoblast activators, growth factors, and herbal products in the local drug delivery system.

This paper presents a case report of a nineteen year old male patient who reported to the dental clinic with a chief complaint of pain in his upper left back tooth. The patient was in good health and his prenatal and post natal history was uneventful. The child was born to non consanguineous parents. His medical history was non-relevant. There was no history of extractions or any oral surgical procedures. The dentition of the parents and sibling were normal. Details of family history revealed absence of any sign, symptom or disease in his cousins/relatives.A complete medical examination was done to rule out any systemic abnormality. The general and physical examination of hair, nails, sweat glands, eyes, and cheeks showed no positive findings. No significant abnormality was revealed in extra oral examination. Upon intra oral examination, the entire mucosa appeared apparently normal.
The hard tissue examination revealed certain findings. The maxillary arch showed the deciduous molars are retained on both the sides and the upper left third molar is visible only as a slight single cusp. On clinical examination, retained deciduous maxillary left first molar (64) and right second molar (55) with dentinal caries were found. There was no evidence of mobility with retained deciduous molars. The other teeth present in the oral cavity were of normal size, shape and color. The clinical photograph of mandibular arch showed retained deciduous molars only on the left side whereas on right side there was normal eruption of the premolars.

Dry powder inhalers (DPIs) are commonly employed in the management of asthma and other diseases with airway obstruction. A causal relationship of DPI use and occurrence of dental caries has been speculated. The present case-control study was therefore designed to examine the potential link between dental caries and specific use of dry powder inhalers in patients with bronchial asthma.